Different moieties of tautomycin involved in protein phosphatase inhibition and induction of apoptosis

Biochemical Pharmacology

Volumn 55, Issue 7, 1998, Pages 995-1003

  Kawamura, Takeshi ^a   Matsuzawa, Shu Ichi ^a   Mizuno, Yusuke ^a   Kikuchi, Kunimi ^a   Oikawa, Hideaki ^a   Oikawa, Masato ^a   Ubukata, Makoto ^b   Ichihara, Akitami ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b TOYAMA PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Antibiotic; Apoptosis; Inhibitor; Jurkat cell; Protein phosphatase; Tautomycin

Indexed keywords

ANTIBIOTIC AGENT; ISOENZYME; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; TAUTOMYCIN; TAUTOMYCIN DERIVATIVE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME STRUCTURE; ESTERIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SKELETAL MUSCLE; STRUCTURE ACTIVITY RELATION;

ANTIBIOTICS, ANTIFUNGAL; APOPTOSIS; CATALYSIS; DETERGENTS; DNA, NEOPLASM; ENZYME INHIBITORS; HUMANS; ISOENZYMES; JURKAT CELLS; PHOSPHOPROTEIN PHOSPHATASE; POLYETHYLENE GLYCOLS; PYRANS; SPIRO COMPOUNDS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032055256     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00539-X     Document Type: Article

References (21)

1. Cheng X-C, Kihara T., Kusakabe H., Magae J., Kobayashi Y., Fang R-P, Ni Z-F, Shen Y-C, Ko K., Yamaguchi I., Isono K. A new antibiotic, tautomycin. J Antibiot (Tokyo). 40:1987;907-909.
2. Ubukata M., Cheng X-C, Isono K. The structure of tautomycin, a regulator of eukaryotic cell growth. J Chem Soc Chem Commun. 1990;244-246.
3. Cheng X-C, Ubukata M., Isono K. The structure of tautomycin, a dialkylmaleic anhydride antibiotic. J Antibiot (Tokyo). 43:1990;809-819.
4. MacKintosh C., Klumpp S. Tautomycin from the bacterium Streptomyces verticillatus. Another potent and specific inhibitor of protein phosphatases 1 and 2A. FEBS Lett. 277:1990;137-140.
5. Hori M., Magae J., Han Y.G., Hartshorne D.J., Karaki H. A novel protein phosphatase inhibitor, tautomycin. Effect on smooth muscle. FEBS Lett. 285:1991;145-148.
6. Suganuma M., Okabe S., Sueoka E., Nishiwaki R., Komori A., Uda N., Isono K., Fujiki H. Tautomycin An inhibitor of protein phosphatase 1 and 2A but not a tumor promoter on mouse skin and in rat glandular stomach . J Cancer Res Clin Oncol. 121:1995;621-627.
7. Hescheler J., Mieskes G., Rüegg J.C., Takai A., Trautwein W. Effects of a protein phosphatase inhibitor, okadaic acid, on membrane currents of isolated guinea-pig cardiac myocytes. Pflügers Arch. 412:1988;248-252.
8. Inomata M., Saijo N., Kawashima K., Kaneko A., Fujiwara Y., Kunikane H., Tanaka Y. Induction of apoptosis in cultured retinoblastoma cells by the protein phosphatase inhibitor, okadaic acid. J Cancer Res Clin Oncol. 121:1995;729-738.
9. Boe R., Gjertsen B.T., Vintermyr O.K., Houge G., Lanotte M., Doskeland S.O. The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells. Exp Cell Res. 195:1991;237-246.
10. Oikawa M., Ueno T., Oikawa H., Ichihara A. Total synthesis of tautomycin. J Org Chem. 60:1995;5048-5068.
11. Resink T.J., Hemmings B.A., Tung H.Y., Cohen P. Characterization of a reconstituted Mg-ATP-dependent protein phosphatase. Eur J Biochem. 133:1983;455-461.
12. Cohen P., Alemany S., Hemmings B.A., Resink T.J., Strålfors P., Lim Tung H.Y. Protein phosphatase-1 and protein phosphatase-2A from rabbit skeletal muscle. Methods Enzymol. 159:1988;390-408.
13. Fischer E.H., Krebs E.G. The isolation and crystallization of rabbit skeletal muscle phosphorylase b. J Biol Chem. 231:1958;65-71.
14. Matsuzawa S-I, Tamura T., Mizuno Y., Kobayashi S-I, Okuyama H., Tsukitani Y., Uemura D., Kikuchi K. Increase in potential activities of protein phosphatases PP1 and PP2A in lymphoid tissues of autoimmune MRL/MpJ-lpr/lpr mice. J Biochem (Tokyo). 111:1992;472-477.
15. Mosmann T. Rapid colorimetric assay for cellular growth and survival Application to proliferation and cytotoxicity assays . J Immunol Methods. 65:1983;55-63.
16. Darzynkiewicz Z., Li X., Gong J. Assay of cell viability Discrimination of cells dying by apoptosis . Methods Cell Biol. 41:1994;1-38.
17. Wyllie A.H., Kerr J.F., Currie A.R. Cell death The significance of apoptosis . Int Rev Cytol. 68:1980;251-306.
18. Namboodiripad A.N., Jennings M.L. Permeability characteristics of erythrocyte membrane to okadaic acid and calyculin A. Am J Physiol. 270:1996;C449-C456.
19. Singh S.B., Zink D.L., Liesch J.M., Goetz M.A., Jenkins R.G., Nallin-Omstead M., Silverman K.C., Bills G.F., Mosley R.T., Gibbs J.B., Albers-Schonberg G., Lingham R.B. Isolation and structure of chaetomellic acids A and B from Chaetommela acutiseta farnesyl pyrophosphate mimic inhibitors of Ras farnesyl-protein transferase. Tetrahedron. 49:1993;5917-5926.
20. Nishiyama U., Ubukata M., Magae J., Kataoka T., Erdödi F., Hartshorne D.J., Isono K., Nagai K., Osada H. Structure-activity relationship within a series of degradation products of tautomycin. Biosci Biotech Biochem. 60:1996;103-107.
21. Sugiyama Y., Ohtani I., Isobe M., Takai A., Ubukata M., Isono K. Molecular shape analysis and activity of tautomycin, a protein phosphatase inhibitor. Bioorg Med Chem Lett. 6:1996;3-8.